Anywhere Dx

Anywhere Dx

United StatesUnited States
•Seed•Founded 2025•Updated 3h ago
HealthtechBio Tech/Life SciencesB2B2C1-5 employees
Serial EntrepreneurSerial EntrepreneurExited FounderExited FounderPhD FounderPhD Founder

About

Anywhere Dx is building a single-use, at-home molecular test for Group A Strep that requires no instrument, lab, or reader. The test collects saliva, purifies and amplifies the target in a disposable cartridge, and reads the result with the naked eye in under 30 minutes. The company aims to make lab-grade diagnosis as accessible as a pregnancy test, with a positive result routing directly to a telehealth visit and prescription.

Traction & Metrics

Fundraising

$1.3M

Previous Round

Team

Nathalya

Nathalya

CEO

Michael

Michael

Other

Nikhil

Nikhil

Other

Products

Anywhere Dx Strep A Molecular Test

A single-use, instrument-free molecular test for Group A Strep that brings lab-grade accuracy to the home. Users provide a saliva sample with no throat swab, and the cartridge integrates bead-based capture, isothermal LAMP amplification with a low-voltage heater, and lateral flow readout. Results are read by the naked eye in under 30 minutes, and a positive result connects to a telehealth visit and prescription, with an out-of-pocket target under $25.

Click to read more